Jakob R. Izbicki
Universität Hamburg, University Medical Center Hamburg-Eppendorf
Papers
16
Total Citations
394
H-Index
11
About
Jakob R. Izbicki is a leading figure in gastrointestinal surgical oncology, with a primary focus on advancing minimally invasive techniques for pancreatic, esophageal, and rectal cancers. His major contributions lie in standardizing and evaluating robotic-assisted surgeries. He co-authored the 2020 ISGPS expert consensus guidelines for managing the pancreatic transection plane after distal pancreatectomy (73 citations), establishing a critical benchmark for pancreatic surgery. Izbicki has been instrumental in comparing robotic approaches with transanal total mesorectal excision (TaTME) for rectal cancer, demonstrating through a 115-case comparison and a prospective multicenter study that robotic surgery preserves anorectal, sexual, and urinary function. His meta-analysis on robotic rectal resection (34 citations) further solidified these functional benefits. Beyond rectal surgery, he has driven standardization in robotic esophagectomy, contributing to the German da Vinci Xi registry trial and recommending a uniform Ivor Lewis procedure. With multiple papers exceeding 30 citations, Izbicki’s work has shaped clinical guidelines and improved patient outcomes, establishing him as a key authority in robotic gastrointestinal surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9Evaluation of the robotic approach concerning pitfalls in rectal surgery19 citations · 2017
- 10